The storage and use of biomaterial samples is an important requirement for accompanying research and the acquisition of new knowledge to improve prognosis and therapy. Biobanking is explicitly recommended in official guidelines. In order to preserve the biomaterial, the patient must consent to the removal, transfer and storage of the biomaterial separately from the consent to the register. The biomaterial is taken at times at which a blood or urine sampling takes place anyway in the clinical routine. Therefore no additional interventions are necessary.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* patients after admission to the intensive care unit
* 18 years or older
* signed informed consent
Exclusion Criteria:
* No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.
Primary outcome measure(s)
Interleukin 6 value [nmol/l] — 10 days Record of clinically relevant parameters
Interleukin 10 [nmol/l] — 10 days Record of clinically relevant parameters
Adrenomedullin value [nmol/l] — 10 days Record of clinically relevant parameters
Tumornekrosefaktor alpha [nmol/l] — 10 days Record of clinically relevant parameters
Procalcitonin [nmol/l] — 10 days Record of clinically relevant parameters
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.